Heat Shock Proteins Accelerate the Maturation of Brain Endothelial Cell Glucocorticoid Receptor in Focal Human Drug-Resistant Epilepsy.
ATP Binding Cassette Transporter, Subfamily B
/ metabolism
Adenosine Triphosphatases
/ metabolism
Adolescent
Adult
Aged
Biological Availability
Blood-Brain Barrier
/ drug effects
Brain
/ pathology
Cell Nucleus
/ drug effects
Child
Cytochrome P-450 Enzyme System
/ metabolism
Drug Resistant Epilepsy
/ metabolism
Endothelial Cells
/ metabolism
Female
Gene Silencing
/ drug effects
Heat-Shock Proteins
/ metabolism
Humans
Male
Middle Aged
Oxcarbazepine
/ pharmacology
Permeability
Phenytoin
/ pharmacology
Protein Transport
/ drug effects
Receptors, Glucocorticoid
/ metabolism
Young Adult
Blood-brain barrier
Drug resistance
Glucocorticoid receptor
Heat shock proteins
Nuclear translocation
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
27
01
2020
accepted:
24
07
2020
pubmed:
5
8
2020
medline:
30
6
2021
entrez:
5
8
2020
Statut:
ppublish
Résumé
Pharmacoresistance in epilepsy is a major challenge to successful clinical therapy. Glucocorticoid receptor (GR) dysregulation can affect the underlying disease pathogenesis. We recently reported that local drug biotransformation at the blood-brain barrier is upregulated by GR, which controls drug-metabolizing enzymes (e.g., cytochrome P450s, CYPs) and efflux drug transporters (MDR1) in human epileptic brain endothelial cells (EPI-ECs). Here, we establish that this mechanism is influenced upstream by GR and its association with heat shock proteins/co-chaperones (Hsps) during maturation, which differentially affect human epileptic (EPI) tissue and brain endothelial cells. Overexpressed GR, Hsp90, Hsp70, and Hsp40 were found in EPI vs. NON-EPI brain regions. Elevated neurovascular GR expression and co-localization with Hsps was evident in the EPI regions with cortical dysplasia, predominantly in the brain micro-capillaries and neurons. A corresponding increase in ATPase activity (*p < 0.05) was found in the EPI regions. The GR-Hsp90/Hsp70 binding patterns indicated a faster chaperone-promoted maturation of GR, leading to its overactivation in both the tissue and EPI-ECs derived from EPI/focal regions and GR silencing in EPI-ECs slowed such GR-Hsp interactions. Significantly accelerated GR nuclear translocation was determined in EPI-ECs following treatment with GR modulators/ligands dexamethasone, rifampicin, or phenytoin. Our findings reveal that overexpressed GR co-localizes with Hsps in the neurovasculature of EPI brain, increased GR maturation by Hsps accelerates EPI GR machinery, and furthermore this change in EPI and NON-EPI GR-Hsp interaction alters with the age of seizure onset in epileptic patients, together affecting the pathophysiology and drug regulation in the epileptic brain endothelium.
Identifiants
pubmed: 32748370
doi: 10.1007/s12035-020-02043-9
pii: 10.1007/s12035-020-02043-9
pmc: PMC7530040
mid: NIHMS1617575
doi:
Substances chimiques
ABCB1 protein, human
0
ATP Binding Cassette Transporter, Subfamily B
0
Heat-Shock Proteins
0
Receptors, Glucocorticoid
0
Phenytoin
6158TKW0C5
Cytochrome P-450 Enzyme System
9035-51-2
Adenosine Triphosphatases
EC 3.6.1.-
Oxcarbazepine
VZI5B1W380
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4511-4529Subventions
Organisme : NHLBI NIH HHS
ID : R56 HL139564
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS078307
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS078307
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS095825
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS095825
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL150049
Pays : United States
Organisme : National Heart, Lung, and Blood Institute/National Institute of Health
ID : R56HL139564
Références
Epilepsia. 2017 Apr;58(4):576-585
pubmed: 28199000
Anal Biochem. 1997 Nov 15;253(2):162-8
pubmed: 9367498
Nature. 2003 Sep 25;425(6956):407-10
pubmed: 14508491
Trends Pharmacol Sci. 2013 Sep;34(9):518-30
pubmed: 23953592
Epilepsia. 2001 Dec;42(12):1501-6
pubmed: 11879359
Epilepsia. 2015 Mar;56(3):439-49
pubmed: 25656284
Mol Cell. 1998 Jun;1(7):959-68
pubmed: 9651579
Transl Psychiatry. 2018 Mar 1;8(1):53
pubmed: 29491368
Cell Mol Life Sci. 2014 Jul;71(13):2499-515
pubmed: 24522255
N Engl J Med. 2011 Sep 8;365(10):919-26
pubmed: 21899452
Nat Rev Cancer. 2005 Oct;5(10):761-72
pubmed: 16175177
J Cereb Blood Flow Metab. 2015 Jul;35(7):1191-8
pubmed: 25757751
J Exp Med. 2017 Feb;214(2):547-563
pubmed: 28028152
FASEB J. 2019 Sep;33(9):9885-9896
pubmed: 31170354
Mol Neurobiol. 2019 Dec;56(12):8392-8407
pubmed: 31243719
Drug Discov Today. 2016 Oct;21(10):1609-1619
pubmed: 27312874
Epilepsia. 2018 Nov;59(11):2049-2060
pubmed: 30264400
Epilepsia. 2011 Mar;52(3):562-71
pubmed: 21294720
F1000Res. 2017 Jul 24;6:1208
pubmed: 28781762
Neuroscience. 2013;255:265-77
pubmed: 24096135
Ann N Y Acad Sci. 2006 Jun;1069:1-9
pubmed: 16855130
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):12998-3003
pubmed: 22837396
Epilepsia. 2007 Mar;48(3):505-16
pubmed: 17326793
Mol Cell Endocrinol. 2013 Nov 5;380(1-2):41-54
pubmed: 23267834
Mol Neurobiol. 2019 Jul;56(7):4904-4915
pubmed: 30414085
J Neurochem. 2008 Dec;107(5):1335-46
pubmed: 18808451
PLoS One. 2018 Feb 7;13(2):e0191270
pubmed: 29415049
Pharm Res. 2014 Jun;31(6):1588-604
pubmed: 24477677
Cell. 2014 Jun 19;157(7):1685-97
pubmed: 24949977
J Neurochem. 2006 Aug;98(4):1176-84
pubmed: 16895583
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):2-12
pubmed: 17628337
Neurobiol Aging. 2013 Jun;34(6):1662-73
pubmed: 23290588
Biotechniques. 2002 Mar;32(3):636-8, 640, 642 passim
pubmed: 11911666
Drug Discov Today. 2020 Jan;25(1):89-106
pubmed: 31541713
Mol Cell Biol. 2006 Nov;26(22):8385-95
pubmed: 16982694
Expert Rev Neurother. 2009 Dec;9(12):1791-802
pubmed: 19951138
Cell Tissue Res. 2014 Mar;355(3):597-605
pubmed: 24352805
Epilepsy Res. 2011 Jun;95(1-2):20-34
pubmed: 21439793
Trends Endocrinol Metab. 2001 Apr;12(3):122-6
pubmed: 11306337
J Clin Invest. 2017 Apr 3;127(4):1136-1145
pubmed: 28319043
PLoS One. 2015 Mar 10;10(3):e0120538
pubmed: 25756665
FASEB J. 2011 Jun;25(6):2049-60
pubmed: 21357526
J Clin Invest. 2005 Jan;115(1):177-86
pubmed: 15630458
Epilepsia. 2014 Nov;55(11):1834-43
pubmed: 25244257
Neurobiol Dis. 2012 Jun;46(3):692-700
pubmed: 22426401
J Biol Chem. 1993 Oct 15;268(29):21455-8
pubmed: 8407992
Ann Neurol. 1998 Oct;44(4):584-91
pubmed: 9778256
J Pharmacol Exp Ther. 2009 Apr;329(1):141-9
pubmed: 19147857
Epilepsia. 2010 Aug;51(8):1408-17
pubmed: 20074231
Epilepsia. 2009 Apr;50(4):664-77
pubmed: 19175391